These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The future of red blood cell alloimmunization risk reduction. Karafin MS; Denomme GA; Bryant BJ Transfusion; 2015 Jan; 55(1):220-1. PubMed ID: 25582238 [No Abstract] [Full Text] [Related]
3. Prospective antigen matching strategies fail to fit the model. Webb J; Chou ST Transfusion; 2015 Jan; 55(1):221-2. PubMed ID: 25582239 [No Abstract] [Full Text] [Related]
4. The future of red blood cell alloimmunization risk reduction. Kacker S; Ness PM; Shirey RS; Savage WJ; King KE; Tobian AA Transfusion; 2015 Jan; 55(1):222-4. PubMed ID: 25582240 [No Abstract] [Full Text] [Related]
5. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom. Mijovic A; Perera IG; Thein SL Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815 [No Abstract] [Full Text] [Related]
6. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771 [TBL] [Abstract][Full Text] [Related]
7. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [TBL] [Abstract][Full Text] [Related]
8. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Harm SK; Yazer MH; Monis GF; Triulzi DJ; Aubuchon JP; Delaney M Am J Clin Pathol; 2014 Feb; 141(2):256-61. PubMed ID: 24436274 [TBL] [Abstract][Full Text] [Related]
9. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Vichinsky EP Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146 [No Abstract] [Full Text] [Related]
10. Red cell transfusions for patients with sickle cell disease: do we have more to learn? Nuss R Pediatr Blood Cancer; 2010 Apr; 54(4):499-500. PubMed ID: 19998466 [No Abstract] [Full Text] [Related]
11. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582 [TBL] [Abstract][Full Text] [Related]
12. Allosensitization in patients receiving multiple blood transfusions. Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705 [TBL] [Abstract][Full Text] [Related]
13. For the patient. Alloimmunization: one risk of treating sickle cell disease. Ethn Dis; 2010; 20(2):195. PubMed ID: 20506598 [No Abstract] [Full Text] [Related]